Literature DB >> 15194550

Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia.

Francesco Baudo, Francesco de Cataldo, Gianluca Gaidano.   

Abstract

We report on the data collected in the Italian Registry of acquired haemophilia (AH) in 2001. Recombinant activated factor VII (rFVIIa) was selected as first-line therapy in 19 bleeding episodes because of their severity and as salvage in one case. Bleeding was controlled in 90% of the episodes, indicating the efficacy of rFVIIa in HA.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15194550

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  9 in total

Review 1.  Recombinant factor VIIa (Eptacog Alfa): a review of its use in congenital or acquired haemophilia and other congenital bleeding disorders.

Authors:  M Asif A Siddiqui; Lesley J Scott
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Recombinant factor VIIa: a review on its clinical use.

Authors:  Massimo Franchini
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

3.  Management of bleeding in acquired haemophilia A with recombinant activated factor VII: does one size fit all? A report of four cases.

Authors:  Mirko Di Capua; Antonio Coppola; Assunta Nardo; Ernesto Cimino; Matteo N D Di Minno; Antonella Tufano; Rosaria Mormile; Maria L Burzo; Giovanni Di Minno; Anna M Cerbone
Journal:  Blood Transfus       Date:  2014-06-19       Impact factor: 3.443

Review 4.  Diagnosis, laboratory aspects and management of acquired hemophilia A.

Authors:  Vincenzo Toschi; Francesco Baudo
Journal:  Intern Emerg Med       Date:  2010-04-21       Impact factor: 3.397

Review 5.  Recombinant activated factor VII in clinical practice: a 2014 update.

Authors:  Massimo Franchini; Silvia Crestani; Francesco Frattini; Cinzia Sissa; Carlo Bonfanti
Journal:  J Thromb Thrombolysis       Date:  2015-02       Impact factor: 2.300

Review 6.  Interventions for treating acute bleeding episodes in people with acquired hemophilia A.

Authors:  Yan Zeng; Ruiqing Zhou; Xin Duan; Dan Long; Songtao Yang
Journal:  Cochrane Database Syst Rev       Date:  2014-08-28

7.  A case of acquired hemophilia A diagnosed after percutaneous endoscopic gastrostomy.

Authors:  Takuma Okamura; Michiharu Komatsu; Akihiro Ito; Tetsuya Ito; Tomoaki Suga; Norikazu Arakura; Hitoshi Sakai; Eiji Tanaka
Journal:  Clin J Gastroenterol       Date:  2015-09-07

8.  Management of acquired hemophilia A: results from the Spanish registry.

Authors:  María-Eva Mingot-Castellano; Josep Pardos-Gea; Saturnino Haya; José-María Bastida-Bermejo; Dolors Tàssies; Ana Marco-Rico; Ramiro Núñez; Faustino García-Candel; María-Carmen Fernández-Sanchez de Mora; Inmaculada Soto; María-Teresa Álvarez-Román; Susana Asenjo; Marina Carrasco; Rafael Lluch-García; José-Manuel Martín-Antorán; Agustín Rodríguez-Alén; Elena Roselló; Laura Torres-Miñana; Shally Marcellini-Antonio; Ana Moretó-Quinana; José-Antonio Rodríguez-García; Reyes Aguinaco-Culebras; Nieves Alonso-Escobar; Carlos Cervero-Santiago; Núria Fernández-Mosteirín; María-Paz Martínez-Badás; Montserrat Pérez-Sánchez; Rocío Pérez-Montes; Ramón Rodríguez-González; Marisol Uribe-Barrientos; Isabel Socorro Caparrós-Miranda; Miriam Iglesias-Fernández; Ángela Baena; Manuel Rodríguez-López; Ana Sebrango-Sandia; Irene Vázquez-Fernández; Pascual Marco
Journal:  Blood Adv       Date:  2021-10-12

Review 9.  Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia.

Authors:  Andreas Tiede; Andrew Worster
Journal:  Ann Hematol       Date:  2018-05-26       Impact factor: 3.673
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.